Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the ClinicalTrials.gov entry; no study details or results were affected.
    Difference
    0.1%
    Check dated 2026-05-15T06:53:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer revision version was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site version change rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:16.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:51.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page's version history.
    Difference
    0.1%
    Check dated 2026-03-19T04:41:21.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Updated the page revision from v3.4.2 to v3.4.3 in the footer.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:28.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 was added and the previous revision notice v3.4.1 along with the government-funding/operating status notice were removed.
    Difference
    0.5%
    Check dated 2026-02-11T12:18:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.